Fundz

CoRegen, Inc. raised over $93M to advance its cancer treatments, funded by undisclosed investors. The funds will support clinical trials and company expansion.

PRIVATEJul 09, 2025

Amount Raised

$93 Million

Round Type

Funding Round

HoustonBiotechnologyHealth CareTherapeutics

Description

CoRegen, Inc., a Houston, TX-based biopharmaceutical company, has raised over $93M in financing. The funds will be used to advance chemistry, manufacturing, and controls (CMC) development, and initiate a Phase 1/2 clinical trial for its SRC3-KO program. The company also plans to expand its leadership team with key hires. This funding follows a prior $28M raise in early 2024.

Quick answer

CoRegen raised $93 Million in a Funding Round round, dated July 9, 2025. CoRegen is based in Houston, Texas, United States.

How much did CoRegen raise?
CoRegen raised $93 Million in a Funding Round round on July 9, 2025.
What does CoRegen do?
CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.
Where is CoRegen based and how big is it?
CoRegen is based in Houston, Texas, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as CoRegen that raised within 45 days of this round, from Fundz verified event records.

  • QurAlis raised $20M on August 21, 2025.
  • Calidi Biotherapeutics raised $6.9M (Post-IPO Equity) on August 21, 2025.
  • CILA Therapeutics raised an undisclosed amount (Grant) on August 15, 2025.
  • Eyestem raised $10M (Series B) on August 11, 2025.
  • Tevogen Inc. raised $1M (Funding Round) on August 7, 2025.
  • Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.

Who to call at CoRegen, and when

A new round usually means CoRegen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CoRegen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CoRegen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CoRegen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CoRegen

Location

Houston, Texas, United States

About

CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CoRegen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CoRegen's next move

See what Strategic adds

CoRegen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.